Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.
about
The study about physical activity for subjects with prevention of benign prostate hyperplasia.Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies.A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis.Associations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.Is metabolic syndrome truly a risk factor for male lower urinary tract symptoms or just an epiphenomenon?The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).Impact of behaviour and lifestyle on bladder health.The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancerSerenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study.Metabolic syndrome and BPH: What do we know?Emerging drugs for the treatment of benign prostatic hyperplasia.Comorbidities associated with bladder dysfunction.Characterization of Compounds Acting on the α1A Adrenergic Receptor fromCaulis spatholobiby Cell Membrane Chromatography with Possible Application for Treatment of Benign Prostatic HyperplasiaComparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
P2860
Q34267524-B86B0BC4-1CF9-4398-80DA-FC7651E56D4CQ35228167-74B4E634-D16C-4161-B6C7-8784DCDE637CQ35510256-A52203A9-595A-4538-A89F-F7DA1BE79971Q35690602-02382F05-D321-4C97-997E-1D047F55F1F3Q37274150-22334562-B887-4CFD-838A-104F72E9ACB2Q37577512-0915E326-56F1-4928-B884-5B9A08D3378BQ38104737-F7EBE4E8-D18B-42E1-A4ED-C8A45F24EC69Q38107278-DC250078-82D2-4366-9EB3-CBADF1A427D5Q38176621-0AF83520-07A7-4779-AEF5-6E26AA4C94DEQ38845916-92DAE6C6-A16B-4060-871B-D3CF44A2B58BQ41337202-793580E7-E00A-4BE6-8C57-8A49445B5826Q47140131-5AB9060A-0023-4653-BA9F-F8EBD32799CBQ47553287-5CCA0480-573D-4676-A4AC-3A8CDC92A653Q50728227-CD836063-1C18-48C4-9892-83F28FE98496Q58270526-741B8CCD-5D9D-4694-AEE7-BB95C2614EACQ58802199-E03D348B-F826-48F8-A942-45860CF4EC9E
P2860
Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metabolic syndrome and benign ...... ized etiology, and prevention.
@ast
Metabolic syndrome and benign ...... ized etiology, and prevention.
@en
type
label
Metabolic syndrome and benign ...... ized etiology, and prevention.
@ast
Metabolic syndrome and benign ...... ized etiology, and prevention.
@en
prefLabel
Metabolic syndrome and benign ...... ized etiology, and prevention.
@ast
Metabolic syndrome and benign ...... ized etiology, and prevention.
@en
P2093
P2860
P1476
Metabolic syndrome and benign ...... ized etiology, and prevention.
@en
P2093
Andrea Gallina
Fabio Castiglione
Firas Abdollah
Nazareno Suardi
Umberto Capitanio
P2860
P304
P356
10.4111/KJU.2011.52.8.507
P577
2011-08-22T00:00:00Z